Jorge DiMartino - 04 Jan 2024 Form 4 Insider Report for Kronos Bio, Inc. (KRON)

Role
Chief Medical Officer & VP
Signature
/s/ Allison Frisbee, Attorney-in-Fact
Issuer symbol
KRON
Transactions as of
04 Jan 2024
Net transactions value
-$14,214
Form type
4
Filing time
05 Jan 2024, 18:27:40 UTC
Previous filing
13 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRON Common Stock Sale $14,214 -12,009 -3.7% $1.18 315,246 04 Jan 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold to satisfy estimated tax withholding obligations upon the settlement of restricted stock units.
F2 The weighted average sale price for the transaction reported was $1.1836, and the range of prices were between $1.12 to $1.28. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.